Citation only
via OpenAlex
Telomere Length as a Marker of Cellular Aging Is Associated With Prevalence and Progression of Metabolic Syndrome
Dóra Révész, Yuri Milaneschi, Josine E. Verhoeven, Brenda W.J.H. Penninx
The Journal of Clinical Endocrinology & Metabolism · 2014 · ▲ 134 citations
Abstract
CONTEXT: Metabolic syndrome (MetS) clusters risk factors for age-related conditions including cardiovascular disease and diabetes. Shorter telomere(definition) length (TL), a cellular marker for biological age, may predict an individual's deteriorating metabolic condition. OBJECTIVE: We examined whether shorter baseline TL is associated with a worse metabolic profile and with less favorable trajectories of MetS components over a 6-year follow-up. DESIGN AND SETTING: PARTICIPANTS were part of The Netherlands Study of Depression and Anxiety, an ongoing prospective cohort study with 6-year follow-up. PARTICIPANTS: This study included 2848 participants age 18-65 years. MAIN OUTCOME MEASURES: Baseline TL from leukocytes was determined using qPCR and MetS components (waist circumference, triglycerides, high-density lipoprotein [HDL] cholesterol, systolic blood pressure, and fasting glucose) were determined at baseline, and after 2 and 6 years. Cross-sectional and longitudinal analyses were adjusted for relevant sociodemographic, lifestyle, and health factors. RESULTS: Shorter baseline TL was cross-sectionally associated with HDL (β = -0.016, SE = 0.008, P = .05), waist circumference (β = 0.647, SE = 0.238, P = .007), triglycerides (β = 0.038, SE = 0.009, P < .001), and fasting glucose (β = 0.011, SE = 0.003, P < .001), as well as with the total number of MetS components (β = 0.075, SE = 0.023, P = .001) and the presence of MetS (OR = 1.19; 95% CI, 1.07-1.33; P = .002). Although baseline differences progressively reduced over time, shorter baseline TL was still significantly associated with unfavorable scores of most MetS components at the 2- or 6-year follow-up. CONCLUSIONS: Cellular aging, as assessed by TL, is associated with a higher metabolic risk profile, which remains unfavorable even after a period of 6 years. These findings suggest that cellular aging might play a role in the onset of various aging-related somatic diseases via its effect on metabolic alterations.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1210/jc.2014-1851
- Canonical
- link ↗
- Fetched
- 2026-09-18 MST
Cite this
APA
Révész, D., Milaneschi, Y., Verhoeven, J.E., & Penninx, B.W. (2014). Telomere Length as a Marker of Cellular Aging Is Associated With Prevalence and Progression of Metabolic Syndrome. <em>The Journal of Clinical Endocrinology & Metabolism</em>. https://doi.org/10.1210/jc.2014-1851
Vancouver
Révész D, Milaneschi Y, Verhoeven JE, Penninx BW. Telomere Length as a Marker of Cellular Aging Is Associated With Prevalence and Progression of Metabolic Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2014. doi:10.1210/jc.2014-1851.
BibTeX
@article{dra2014Telome,
title = {Telomere Length as a Marker of Cellular Aging Is Associated With Prevalence and Progression of Metabolic Syndrome},
author = {Dóra Révész and Yuri Milaneschi and Josine E. Verhoeven and Brenda W.J.H. Penninx},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2014},
doi = {10.1210/jc.2014-1851},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Journal of Clinical Endocrinology & Metabolism 2015
Preprint · OA
Longitudinal Associations Between Metabolic Syndrome Components and Telomere Shortening
Diabetic Medicine 2003
Citation only
The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
Clinical epigenetics 2026
Open access · OA
The role of epigenetic age acceleration and social disadvantage in cardiometabolic health in southeast Louisiana women.
Ear and hearing 2026
Citation only
Frailty Progression Moderates the Association Between Sensory and Cognitive Trajectories Over 6 Years: Evidence From the Canadian Longitudinal Study on Aging.
Diabetes Care 2008
Open access · CC-BY
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome
Scientific Reports 2020
Open access · CC-BY